September 23, 2011
HCC and FDA Announce interest sale to Lagniappe Health
Fort Worth, TX (August 25, 2011) - After leading HCC and FDS through decades of developing and delivering technology to the pharmacy and healthcare marketplace, Rex Akers has sold his interest in HCC and FDS to Lagniappe Health.
Going forward, two longtime HCC and FDS executives will assume responsibility for day to day operations. Mike McManus, formerly EVP, Business Development, will assume the role of President and Tracy Ward, formerly EVP, will serve as COO of both HCC and FDS. FDS Specialty Services, a custom software company will be merged into FDS.
"Our founder and owner desired an exit strategy that not only provided him a path to retirement but a future for his employees and customers," said Mike McManus, president of HCC and FDS. "Rather than a strategic buyer, we were able to find a financial partner that enables us to build upon the very fine products and services offered to all the customers of HCC, FDS, and FDS Specialty Services as well as to enable us to expand into additional lines of business," continued McManus. "Our plan is to continue to provide our customers with exceptional products and services as well as to grow our existing companies by adding more services for the health care market."
HCC, Inc. (www.hcc-care.com) offers pharmacy technology solutions including pharmacy management systems with multi-store profile access and prescription transfers, central management services for multi-store operations, innovative pharmacy inventory management, advanced prescription fulfillment workflow systems, POS systems with electronic signature capture and tracking, and transaction based DVR security systems.
FDS, Inc. (www.fdsrx.com) provides health care data services including prescription claims routing, prescription claims reviews & edits, robust data warehousing, e-prescribing, online DME claims processing, claims reconciliation, claims management backend services, patient education programs and revenue enhancing programs.
Lagniappe Health is a portfolio company of Calvert Street Capital Partners (www.cscp.com) focused on healthcare technologies. Founded in 1994, CSCP currently manages over $500 million of invested capital using a proven "buy and build" strategy that identifies scalable, platform companies with opportunities for internal expansion as well as growth through selective add-on acquisitions. CSCP acquires family-owned companies which operate in fragmented industries with predictable and repetitive demand for products and services.
For more information on this transaction, please contact:
Clarence W. Lea, R.Ph.
Chief Marketing Officer
817.513.8992 Ext 236
HCC Press Release